Ashwagandha powder in a wooden bowl next to dried roots on a dark background

Research

Ashwagandha: an adaptogen between tradition and modern research

13 min read

For ashwagandha there are meta-analyses of randomised trials on stress, sleep and endurance.1-3 And there is a 2024 communication from the German Federal Institute for Risk Assessment (BfR). According to it, children, pregnant and breastfeeding women and people with liver disease should not take ashwagandha products, and everyone else only with restraint.4

Both belong together. This article sets out what the studies measured, how solid that is and what is known about safety.

What is ashwagandha?

Ashwagandha (Withania somnifera) is an evergreen shrub of the nightshade family. It is also known as winter cherry or Indian ginseng.4,5 Ayurvedic medicine mainly uses the root. Food supplements contain root powder or extracts, some also from the leaves.4

Ashwagandha shrub with leaves and fruit calyces
Withania somnifera belongs to the nightshade family; its characteristic constituents include the withanolides.

The name comes from Sanskrit: "ashwa" means horse, "gandha" smell.

It refers to the smell of the root, which is reminiscent of a wet horse. The Latin species name somnifera means "sleep-bringing".5

The compounds considered biologically active are mainly the withanolides, a group of steroidal plant compounds, and alkaloids. The plant also contains glycowithanolides and phenolic compounds.4,5 According to the BfR, it is not possible to say which of these substances, in which amounts, account for the study results.4

What does "adaptogen" mean, and is there an authorised health claim?

Ashwagandha is often called an adaptogen. The term comes from herbal medicine and refers to substances credited with a role in the body's stress response.6 It is used broadly today, for example for the medicinal mushrooms cordyceps and hericium. There the same question about the solidity of the data arises.

There is no authorised health claim for ashwagandha. The European Commission has put the assessment of claims on plant substances on hold. In 2025 the Court of Justice of the European Union ruled that as long as this assessment has not been completed, such claims may not be used in advertising for food supplements.7 How the procedure works is explained in the article on EU health claims.

A study result is not an authorised health claim.

The BfR considers the advertised effects scientifically unproven.4 What follows are results from studies, with their limits.

What studies on ashwagandha have measured

Meta-analyses and single trials, mostly around 8 weeks, with different extracts

Stress and anxiety scores12 trials, 1,002 participants, low certainty of evidenceeffect measured
Cortisol9 studies, 30-112 dayseffect measured
Overall sleep5 trials, 400 participantssmall effect
Endurance (VO₂max)4 trials, 142 participants, inconsistentuncertain
Muscle strength1 trial, 57 mensingle trial
Safety over months and yearsadverse effects not recorded systematicallynot studied
Sources as in the sections below: Akhgarjand 2022, Della Porta 2023, Cheah 2021, Pérez-Gómez 2020, Wankhede 2015, BfR 2024. A measured effect is not an authorised health claim.

What do studies show on stress and cortisol?

Stress is the most frequently studied area. A meta-analysis pooled 12 randomised, placebo-controlled trials with 1,002 participants aged 25 to 48. Anxiety and stress scores on questionnaires were lower with ashwagandha than with placebo.1

The authors rate the certainty of this evidence as low for both outcomes. The results of the individual trials varied widely, and high-quality trials are lacking.1

A systematic review of 9 studies in stressed adults found lower cortisol levels with ashwagandha. The studies lasted 30-112 days and differed in preparation and amount. None of them examined what reduced cortisol secretion means for the adrenal glands in the long term.6

A 2025 meta-analysis studied people with a mental disorder, mostly an anxiety disorder. It covered 14 trials with 713 participants, a median of 600 mg a day over 8 weeks. It found lower anxiety scores, but the trials were small and inconsistent.8 A review of plant substances and cognitive performance describes an influence of ashwagandha mainly on anxiety and social cognition.9

What do studies show on sleep?

A meta-analysis of 5 randomised trials with 400 participants found a small but statistically significant effect on overall sleep.2 It was more pronounced in people with diagnosed insomnia, at doses of at least 600 mg a day and with a duration of at least 8 weeks.2

No serious side effects were reported in these trials. The authors nevertheless consider the data on this limited and call for more safety data before long-term use can be judged.2

What do studies show on endurance and strength?

For maximum oxygen uptake (VO₂max), a measure of endurance performance, there is one meta-analysis. In 4 trials with 142 participants it found higher values with ashwagandha. The trials were few, their results inconsistent, and the authors consider confirmation necessary.3

On strength there is mainly a single trial with 57 young men who had little resistance-training experience. They trained for 8 weeks and took 300 mg of root extract or a placebo twice a day.10

Strength training: greater gains with ashwagandha, in a single trial

Gain in maximum strength after 8 weeks of training, in kg

Bench press

Ashwagandha, 2 × 300 mg a day46.0 kg
Placebo26.4 kg

Leg extension

Ashwagandha, 2 × 300 mg a day14.5 kg
Placebo9.8 kg
Source: Wankhede et al. 2015, 57 young men with little training experience, randomised and placebo-controlled. A single trial with a small number of participants.

The ashwagandha group gained more on the bench press and the leg extension. The muscle damage marker creatine kinase remained more stable after training.10 It is striking that the studies so far have mainly included people under increased strain, from stress, lack of sleep or training. Whether that explains the finding or merely describes how the participants were selected remains open.

What is known about hormones and fertility?

The BfR cites indications that ashwagandha products can influence the hormonal system, including cortisol, blood sugar, thyroid and sex hormones.4 A randomised trial studied 50 men with lower sexual desire. With 300 mg of root extract twice a day, testosterone and the scores of a sexual function questionnaire rose more than with placebo.11

A systematic review of reproduction in women and men draws on laboratory, animal and clinical studies. It considers further research on long-term effects and dosing necessary.12

How might ashwagandha act in the body?

Several pathways are discussed. The review on cortisol examined the hypothalamic-pituitary-adrenal axis (HPA axis), the system that controls the stress response through hormones such as cortisol.6 A phytochemical review describes antioxidant properties of the constituents and effects on messenger substances in the nervous system, mainly from laboratory and animal experiments.5

That does not say which constituent explains which finding. The products differ widely: in the part of the plant, the extraction method and the content of constituents.4

What amounts were used in studies?

The studies in this article mostly used root extract, often 300 mg twice a day, i.e. 600 mg a day, over about 8 weeks.8,10,11,13 The review on cortisol included studies of 30-112 days.6 According to the BfR, the consequences of long-term use have been studied only insufficiently.4

The BfR was unable to derive a guidance value for a safe intake.4 There is no legal maximum amount in Germany. Poland limits root powder to 3,000 mg and withanolides to 10 mg a day. Denmark banned ashwagandha in food supplements in 2023.14

What is on a pack is often hard to compare. In a market check by the consumer advice centre of North Rhine-Westphalia, only 20 of 73 products stated the daily amount of ashwagandha or of withanolides. The stated withanolide amounts ranged from 7.5 to 150 mg a day.14

How well tolerated is ashwagandha?

In the studies, ashwagandha was mostly considered well tolerated.2,8 The BfR points out, however, that these studies mainly examined benefits and did not record adverse effects systematically.4

Reported effects include nausea, vomiting and diarrhoea, as well as drowsiness, headache, dizziness, sleepiness and skin rashes.4

Can ashwagandha damage the liver?

Since 2017, case reports of liver injury possibly linked to ashwagandha have been published worldwide, including cases of acute liver failure. According to the BfR, they are reason for particular caution.4

A case series from Iceland and the USA describes 5 people who developed jaundice 2-12 weeks after starting. In 4 of them, liver tests returned to normal after 1-5 months. 4 of the 5 had also taken other food supplements.15 A case series from India describes 8 people who had taken ashwagandha only. 5 already had chronic liver disease; 3 of them developed liver failure and died.16

Liver injury: what 2 case series describe

Individual cases, no statement about frequency

Iceland and the USA, 2016-2018jaundice 2-12 weeks after starting, no liver failure, liver tests normal in 4 after 1-5 months5 cases
India, 2019-2022, ashwagandha only5 with existing liver disease, of whom 3 developed liver failure, all 3 died8 cases
Sources: Björnsson et al. 2020, Philips et al. 2023. Other causes were excluded, and the products analysed were not contaminated. The BfR sees such case reports as reason for particular caution.

Case reports do not prove a causal link; the BfR speaks of a possible one.4 In both series, however, other causes were excluded, and chemical analysis found no contamination of the products examined.15,16

Does ashwagandha affect the thyroid?

Yes, measurements point to it. In a small pilot study, 50 adults with a slightly raised thyroid-stimulating hormone TSH took 600 mg of root extract or a placebo for 8 weeks. With ashwagandha, TSH and the thyroid hormones T3 and T4 changed significantly more than with placebo.13

The BfR had already raised concerns about an influence on thyroid function in 2012. Later assessments from Denmark, the Netherlands, France and Australia also point to an influence.4 How the thyroid makes its hormones is explained in the article on iodine.

What applies in pregnancy, breastfeeding and with medicines?

Safety data are lacking for pregnant and breastfeeding women and for children. Ashwagandha has also historically been said to be used as an abortifacient. The BfR therefore advises these groups not to take it, as well as people with existing or past liver disease.4

There are indications of interactions with medicines for high blood sugar, for high blood pressure and with drugs that suppress the immune system. Anyone taking such medicines should seek medical advice beforehand, according to the BfR.4

What the BfR advised on ashwagandha products in 2024

By population group

Childrensafety data are lackingdo not take
Pregnant and breastfeeding womensafety data are lacking, historically named as an abortifacientdo not take
Existing or past liver diseasecase reports of liver injurydo not take
Drugs for blood sugar, blood pressure, immune responsepossible interactionsmedical advice
Everyone elsedata gaps, no safe guidance valuerestraint
Source: BfR, communication 039/2024 of 10 September 2024.

Many packs lack these warnings. In the consumer advice centre's market check, only 11 of 73 products carried a warning for people with liver disease.14

Warnings on the pack: often missing

Products carrying each warning, out of 73 in the market check

Pregnant and breastfeeding women32 of 73
Children22 of 73
Liver disease11 of 73
Interactions with medicines8 of 73
Source: Verbraucherzentrale North Rhine-Westphalia 2026, sample from shops and online retail in the 2nd half of 2025.

What does the evidence show overall?

Most studies are small, lasted about 8 weeks and used different extracts.1,6,8 For stress and sleep there are meta-analyses with measurable effects, whose solidity the authors themselves rate as limited.1,2 Data on the safety of long-term use are lacking, and the case reports on the liver are to be taken seriously.4

What taking food supplements over the long term means in general is covered in the article on long-term use. What a supplement can and cannot do is set out in the article on diet and supplements.

Key takeaways

  • No authorised health claim: the assessment of claims on plant substances is on hold in the EU, and advertising with them is currently not permitted.7
  • Stress and sleep: meta-analyses found lower stress scores and a small effect on sleep, with low certainty of evidence and mostly 8 weeks' duration.1,2
  • Liver: case reports describe liver injury up to liver failure, especially with existing liver disease.4,16
  • Thyroid and hormones: ashwagandha changed thyroid values in one trial; the BfR cites influences on several hormones.4,13
  • BfR 2024: not to be taken by children, pregnant and breastfeeding women and people with liver disease, restraint for everyone else; there is no safe guidance value.4

Sources

  1. Akhgarjand C, Asoudeh F, Bagheri A, et al. Does Ashwagandha supplementation have a beneficial effect on the management of anxiety and stress? A systematic review and meta-analysis of randomized controlled trials. Phytotherapy Research, 2022.
  2. Cheah KL, Norhayati MN, Husniati Yaacob L, Abdul Rahman R. Effect of Ashwagandha (Withania somnifera) extract on sleep: A systematic review and meta-analysis. PLoS ONE, 2021.
  3. Pérez-Gómez J, Villafaina S, Adsuar JC, et al. Effects of Ashwagandha (Withania somnifera) on VO2max: A Systematic Review and Meta-Analysis. Nutrients, 2020.
  4. German Federal Institute for Risk Assessment (BfR). Ashwagandha: winter cherry preparations with possible health risks (in German). Communication 039/2024 of 10 September 2024, accessed 15 November 2026.
  5. Lerose V, Ponticelli M, Benedetto N, et al. Withania somnifera (L.) Dunal, a Potential Source of Phytochemicals for Treating Neurodegenerative Diseases: A Systematic Review. Plants, 2024.
  6. Della Porta M, Maier JA, Cazzola R. Effects of Withania somnifera on Cortisol Levels in Stressed Human Subjects: A Systematic Review. Nutrients, 2023.
  7. Court of Justice of the European Union. Advertising using health claims relating to botanical substances is currently prohibited. Press release No 57/25 on the judgment of 30 April 2025 in Case C-386/23 (Novel Nutriology), ECLI:EU:C:2025:304.
  8. Marchi M, Grenzi P, Travascio A, et al. The effect of Withania somnifera (Ashwagandha) on mental health symptoms in individuals with mental disorders: systematic review and meta-analysis. BJPsych Open, 2025.
  9. Lorca C, Mulet M, Arévalo-Caro C, et al. Plant-derived nootropics and human cognition: A systematic review. Critical Reviews in Food Science and Nutrition, 2023.
  10. Wankhede S, Langade D, Joshi K, Sinha SR, Bhattacharyya S. Examining the effect of Withania somnifera supplementation on muscle strength and recovery: a randomized controlled trial. Journal of the International Society of Sports Nutrition, 2015.
  11. Chauhan S, Srivastava MK, Pathak AK. Effect of standardized root extract of ashwagandha (Withania somnifera) on well-being and sexual performance in adult males: A randomized controlled trial. Health Science Reports, 2022.
  12. Roy D, Ghosh M, Roy D, et al. Effects of Ashwagandha on Reproductive Health: A Systematic Review of Sex-Specific Hormonal and Fertility Outcomes. Phytotherapy Research, 2026.
  13. Sharma AK, Basu I, Singh S. Efficacy and Safety of Ashwagandha Root Extract in Subclinical Hypothyroid Patients: A Double-Blind, Randomized Placebo-Controlled Trial. Journal of Alternative and Complementary Medicine, 2018.
  14. Consumer Advice Centre North Rhine-Westphalia (Verbraucherzentrale NRW). Ashwagandha in food supplements. Market check report (in German). 20 April 2026, accessed 15 November 2026.
  15. Björnsson HK, Björnsson ES, Avula B, et al. Ashwagandha-induced liver injury: A case series from Iceland and the US Drug-Induced Liver Injury Network. Liver International, 2020.
  16. Philips CA, Valsan A, Theruvath AH, et al. Ashwagandha-induced liver injury - A case series from India and literature review. Hepatology Communications, 2023.

ATLAS All-in-One - 35 ingredients, 4 capsules, once a day.